Schistosomiasis has been classified as a category II disease after malaria in importance targeted tropical disease. Praziquantel (PZQ) which is the chemotherapeutic agent of choice against adult worms, already faces drawback drug resistance some Schistosoma isolates. Therefore, searching for new alternative drugs intention many researchers. In current study, effect different doses 6.25, 12.5, 2...
